In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Myrexis, Inc.

http://www.myrexis.com

Latest From Myrexis, Inc.

Inovio To Streamline COVID-19 Vaccine Program Under New CEO

The company will shift development of INO-4800 to a booster strategy. It also announced it must conduct additional studies of the cervical dysplasia drug VGX-3100 after an FDA meeting.

Coronavirus COVID-19 Vaccines

Finance Watch: VC Mega-Rounds Are Alive And Well

Private Company Edition: Also, Catalio closed a $381m venture capital fund and OrbiMed’s SEC filings indicate it is in the process of raising $4.75bn across three new funds. Dianthus launched with $100m and Tubulis closed a $63m series B round.

Financing Innovation

Execs On The Move: April 2022

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Commercial Companies

Execs On The Move, April 2022 Roundup: Shake Ups At Glaukos, Medtronic, BD And Globus

Executives On The Move will be running to a monthly schedule from now, with this edition covering medtech's executive changes for April.

Executive Changes Commercial
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Myriad Pharmaceuticals, Inc.
UsernamePublicRestriction

Register